Previous 10 | Next 10 |
- Will support Sera’s Transition from clinical to commercial stage company - - Sera positioned for growth with several outcome study read-outs taking place in 2020 - SALT LAKE CITY, April 02, 2020 (GLOBE NEWSWIRE) -- Sera Prognostics, Inc., The Pregnancy Company...
Achieve Life Sciences, Inc. (ACHV) Q4 2019 Results Earnings Conference Call March 13, 2020, 08:30 AM ET Company Participants Jaime Xinos - Executive Vice President of Commercial Richard Stewart - Chief Executive Officer John Bencich - Chief Financial Officer Cindy Jacobs - Exec...
Achieve Life Sciences ( ACHV ) Q4 results : Revenues: $0; Net loss: ($3.2M) (+11.1%); loss/share: ($0.30) (+45.5%). More news on: Achieve Life Sciences, Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, , Read more ...
Achieve Life Sciences (NASDAQ: ACHV ): Q4 GAAP EPS of -$0.30 beats by $0.02 . More news on: Achieve Life Sciences, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...
SEATTLE and VANCOUVER, British Columbia , March 13, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, toda...
SEATTLE and VANCOUVER, British Columbia , March 12, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, announ...
SEATTLE and VANCOUVER, British Columbia , Feb. 6, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine addiction, today ...
Achieve Life Sciences (NASDAQ: ACHV ), University of Bristol, and Oracle (NYSE: ORCL ) announce the outcome of a study using Oracle's cloud infrastructure to improve the speed of drug discovery and development of new treatments. More news on: Achieve Life Sciences, Inc., Oracle Corporati...
SEATTLE and VANCOUVER, British Columbia , Jan. 13, 2020 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), University of Bristol , and Oracle Corporation (NYSE: ORCL) today announced the outcome of a study using Oracle's high-performance cloud infrastructure to potentiall...
Achieve Life Sciences, Inc. Announces Closing of $13.8 Million Underwritten Public Offering, Including Full Exercise of Overallotment Option Canada NewsWire SEATTLE and VANCOUVER, British Columbia, Dec. 19, 2019 SEATTLE and VANCOUVER, British Columbia , Dec. 19, 2019 ...
News, Short Squeeze, Breakout and More Instantly...
Achieve Life Sciences Inc. Company Name:
ACHV Stock Symbol:
NASDAQ Market:
Achieve Life Sciences Inc. Website:
– Two New Independent Directors, Stuart Duty and Andrew Saik, Appointed – Third New Independent Director to Be Appointed to Board in Near Term MONTREAL and CHARLOTTE, N.C., July 15, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) (...
SEATTLE and VANCOUVER, British Columbia, July 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that...
SEATTLE and VANCOUVER, British Columbia, July 01, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, announced that the c...